Efficacy of mifepristone in reducing intermenstrual vaginal bleeding in users of the levonorgestrel intrauterine system

International Journal of Gynecology and Obstetrics

Volumn 109, Issue 2, 2010, Pages 128-130

  Lal, Suman ^a   Kriplani, Alka ^a   Kulshrestha, Vidushi ^a   Sharma, Meenakshi ^a   Agarwal, Nutan ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Intermenstrual bleeding; Levonorgestrel intrauterine system; LNG IUS; Mifepristone; Vaginal bleeding

Indexed keywords

LEVONORGESTREL; MIFEPRISTONE;

ACNE; ADULT; ARTICLE; BACKACHE; BREAKTHROUGH BLEEDING; BREAST TENDERNESS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; ENDOMETRIUM BIOPSY; FEMALE; HAIR LOSS; HUMAN; HUMAN TISSUE; INSOMNIA; INTRAUTERINE CONTRACEPTIVE DEVICE; MENORRHAGIA; MENSTRUATION; PATIENT SATISFACTION; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT RESPONSE;

EID: 77950519713     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2010.01.015     Document Type: Article

References (14)

1. Kriplani A., Singh B.M., Lal S., and Agarwal N. Efficacy, acceptability and side effects of the levonorgestrel intrauterine system for menorrhagia. Int J Gynecol Obstet 97 3 (2007) 190-194
2. Busfield R.A., Farquhar C.M., Sowter M.C., Lethaby A., Sprecher M., Yu Y., et al. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding. BJOG 113 3 (2006) 257-263
3. Datey S., Gaur L.N., and Saxena B.N. Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IUDS, oral pills) -- an Indian experience. An ICMR Task Force study. Indian council of Medical Research. Contraception 51 3 (1995) 155-165
4. Hickey M., and d'Arcangues C. Vaginal bleeding disturbances and implantable contraceptives. Contraception 65 1 (2002) 75-84
5. Abdel-Aleem H., d'Arcangues C., Vogelsong K.M., and Gulmezoglu A.M. Treatment of vaginal bleeding irregularities induced by progestin only contraceptives. Cochrane Database Syst Rev 4 (2007) CD003449
6. Tantiwattanakul P., and Taneepanichskul S. Effect of mefenamic acid on controlling irregular uterine bleeding in DMPA users. Contraception 70 4 (2004) 277-279
7. Senthong A.J., and Taneepanichskul S. The effect of tranexamic acid for treatment irregular uterine bleeding secondary to DMPA use. Med Assoc Thai 92 4 (2009) 461-465
8. Jain J.K., Nicosia A.F., Nucatola D.L., Lu J.J., Kuo J., and Felix J.C. Mifepristone for the prevention of breakthrough bleeding in new starters of depo-medroxyprogesterone acetate. Steroids 68 10-13 (2003) 1115-1119
9. Cheng L., Zhu H., Wang A., Ren F., Chen J., and Glasier A. Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrel. Hum Reprod 15 9 (2000) 1969-1972
10. Massai M.R., Pavez M., Fuentealba B., Croxatto H.B., and d'Arcangues C. Effect of intermittent treatment with mifepristone on bleeding patterns in Norplant implant users. Contraception 70 1 (2004) 47-54
11. Jain J.K., Li A., Yang W., Minoo P., and Felix J.C. Effects of mifepristone on proliferation and apoptosis of human endometrium in new users of medroxyprogesterone acetate. Hum Reprod 21 3 (2006) 798-809
12. Glasier A.F., Wang H., Davie J.E., Kelly R.W., and Critchley H.O. Administration of an antiprogesterone up-regulates estrogen receptors in the endometrium of women using Norplant: a pilot study. Fertil Steril 77 2 (2002) 366-372
13. Jain J.K., Li A., Yang W., Minoo P., and Felix J.C. Mifepristone alters expression of endometrial steroid receptors and their cofactors in new users of medroxyprogesterone acetate. Fertil Steril 87 1 (2007) 8-23
14. Higham J.M., O'Brien P.M., and Shaw R.W. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynecol 97 8 (1990) 734-739